CAS: 1038922-95-0; (2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5R,6R)-3,5-Dihydroxy-2-(((4S,5'R,6Ar,6Bs,8As,8Bs,9S,10R,11As,12As,12Br)-8B-Hydroxy-5',6A,8A,9-Tetramethyl-1,3,3',4,4',5,5',6,6A,6B,6',7,8,8A,8B,9,11A,12,12A,12B-Icosahydrospiro[naphtho[2',1':4,5]Indeno[2,1-B]Furan-10,2'-Pyran]-4-yl)Oxy)-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-4-yl)Oxy)-6-Methyltetrahydro-2H-Pyran-3,4,5-Triol
该化合物是一种具有独特结构特征的生物活性化合物,该化合物具有强大的药理特性,在药物发现和开发中具有潜在的应用作用,其特定的结构安排和功能组有助于它与生物受体有选择地互动,使其成为医学化学研究的宝贵工具.
- 英文名称(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5R,6R)-3,5-Dihydroxy-2-(((4S,5'R,6Ar,6Bs,8As,8Bs,9S,10R,11As,12As,12Br)-8B-Hydroxy-5',6A,8A,9-Tetramethyl-1,3,3',4,4',5,5',6,6A,6B,6',7,8,8A,8B,9,11A,12,12A,12B-Icosahydrospiro[naphtho[2',1':4,5]Indeno[2,1-B]Furan-10,2'-Pyran]-4-yl)Oxy)-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-4-yl)Oxy)-6-Methyltetrahydro-2H-Pyran-3,4,5-Triol
- 中文名称(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5R,6R)-3,5-二羟基-2-(((4S,5'R,6AR,6BS,8AS,8BS,9S,10R,11AS,12AS,12BR)-8B-羟基-5',6A,8A,9-四甲基-1,3,3',4,4',5,5',6,6A,6B,6',7,8,8A,8B,9,11A,12,12A,12B-二十羟基螺[萘并[2',1':4,5]HO[2,1-B]呋喃-10,2'-吡喃]-4-基)氧基)-6-(羟甲基)四氢-2H-吡喃-4-基)氧基)-6-甲基四氢-2H-吡喃-3,4,5-三醇
- IUPAC名称(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5R,6R)-3,5-dihydroxy-2-(((4S,5'R,6aR,6bS,8aS,8bS,9S,10R,11aS,12aS,12bR)-8b-hydroxy-5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol
- 其它别名(25R)-17α-Hydroxyspirost-5-En-3β-Yl O-α-L-Rhamnopyranosyl-(1→3)-β-D-Glucopyranoside; Mannioside A; (3Beta,25R)-17-Hydroxyspirost-5-En-3-Yl 3-O-(6-Deoxy-Alpha-L-Mannopyranosyl)-Beta-D-Glucopyranoside; β-D-Glucopyranoside, (3β,25R)-17-Hydroxyspirost-5-En-3-Yl 3-O-(6-Deoxy-α-L-Mannopyranosyl)-
- CAS编号1038922-95-0
- MFCD编号:MFCD20260832
- 分子式:C39H62O13分子量:738.91
- 产品CID: 75138

海关参考信息
- 2905122000-异丙醇
2905143000-叔丁醇
2905310000-1,2-乙二醇
2905320000-1,2-丙二醇
2905399001-1,3-丙二醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
✅ COA系统入驻 | 共享模式